News

21.10.2016

Portugal: Newly diagnosed MS athlete becomes bodysurf champion

The Portuguese MS Society (SPEM) announced that recently diagnosed bodysurfer and runner Miguel Rocha (pictured below) won the National Bodysurf…

EMSP launches Membership Newsletter

17.10.2016

We are glad to announce the launch of our Membership Newsletter, available as of 17 October 2016. The newsletter is a collaborative initiative made possible with the great support of MS societies across Europe.

EMSP launches Membership Newsletter

17.10.2016

We are glad to announce the launch of our Membership Newsletter on 17 October 2016. The newsletter is a collaborative…

12.10.2016

World Mental Health Day: Young people in the digital age

EMSP’s partners at Mental Health Europe joined by healthcare stakeholders and policymakers marked World Mental Health Day 2016 with a…

World Mental Health Day: Young people in the digital age

12.10.2016

EMSP’s partners at Mental Health Europe joined by healthcare stakeholders and policymakers marked World Mental Health Day 2016 with a…

European Patient Innovation Summit: Using digital technology to improve patient care

10.10.2016

MSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External Relations Director Christoph Thalheim held a presentation explaining the importance of patient-relevant outcomes.

10.10.2016

European Patient Innovation Summit: Using digital technology to improve patient care

EMSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External…

EURORDIS: Patient survey on adverse drug reactions

27.09.2016

EMSP is supporting a survey intiative from our partners at Rare Diseases Europe (EURODIS) aimed at reporting side-effects and receiving safety information on medicines through an app for mobile phones and tablets.

EURORDIS: Patient survey on adverse drug reactions

27.09.2016

EMSP is supporting a survey intiative from our partners at Rare Diseases Europe (EURORDIS) aimed at reporting side-effects and receiving…

1 35 36 37 38 39 65